Soni J, Pathak N, Gharia M, Aswal D, Parikh J, Sharma P
World J Hepatol. 2025; 17(1):101630.
PMID: 39871911
PMC: 11736475.
DOI: 10.4254/wjh.v17.i1.101630.
Latif S, Ahsan T
Euroasian J Hepatogastroenterol. 2025; 14(2):129-133.
PMID: 39802849
PMC: 11714111.
DOI: 10.5005/jp-journals-10018-1437.
Do A, Zahrawi F, Mehal W
Nat Rev Drug Discov. 2024; 24(3):171-189.
PMID: 39609545
DOI: 10.1038/s41573-024-01084-2.
Us Altay D, Kaya Y, Mataraci Degirmenci D, Kocyigit E, Uner A, Noyan T
J Gastroenterol Hepatol. 2024; 39(12):2723-2734.
PMID: 39343724
PMC: 11660201.
DOI: 10.1111/jgh.16756.
Fitzgerald V, Lutsiv T, McGinley J, Neil E, Playdon M, Thompson H
Nutrients. 2024; 16(18).
PMID: 39339796
PMC: 11434909.
DOI: 10.3390/nu16183196.
Dietary Approaches to Stop Hypertension (DASH) and mortality risk among patients with liver cirrhosis: a prospective cohort study.
Zarei A, Pashayee-Khamene F, Hekmatdoost A, Karimi S, Ahmadzadeh S, Saberifiroozi M
BMC Res Notes. 2024; 17(1):248.
PMID: 39232774
PMC: 11376012.
DOI: 10.1186/s13104-024-06928-z.
Innovative treatments for obesity and NAFLD: A bibliometric study on antioxidants, herbs, phytochemicals, and natural compounds.
Pezzino S, Sofia M, Mazzone C, Litrico G, Greco L, Gallo L
Heliyon. 2024; 10(16):e35498.
PMID: 39220898
PMC: 11365328.
DOI: 10.1016/j.heliyon.2024.e35498.
A Novel Prescription Digital Therapeutic Option for the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease.
Alkhouri N, Edwards K, Berman M, Finn H, Escandon R, Lupinacci P
Gastro Hep Adv. 2024; 3(1):9-16.
PMID: 39132187
PMC: 11307699.
DOI: 10.1016/j.gastha.2023.08.019.
Machine learning uncovers manganese as a key nutrient associated with reduced risk of steatotic liver disease.
Schophaus S, Creasy K, Koop P, Clusmann J, Jaeger J, Punnuru V
Liver Int. 2024; 44(10):2807-2821.
PMID: 39082383
PMC: 11464189.
DOI: 10.1111/liv.16055.
The effects of meal patterns on liver steatosis, fibrosis, and biochemical factors in patients with nonalcoholic fatty liver disease: a randomized controlled clinical trial.
Alizadeh M, Hosseiniazar M, Alami F, Adabi S
J Diabetes Metab Disord. 2024; 23(1):987-997.
PMID: 38932893
PMC: 11196559.
DOI: 10.1007/s40200-023-01375-2.
Non-alcoholic fatty liver disease and gut microbial dysbiosis- underlying mechanisms and gut microbiota mediated treatment strategies.
Jayachandran M, Qu S
Rev Endocr Metab Disord. 2023; 24(6):1189-1204.
PMID: 37840104
DOI: 10.1007/s11154-023-09843-z.
Correspondence on Letter regarding "Risk factors in nonalcoholic fatty liver disease".
Yoon E, Won Jun D
Clin Mol Hepatol. 2023; 29(4):1050-1051.
PMID: 37718595
PMC: 10577338.
DOI: 10.3350/cmh.2023.0310.
Plasma Fatty Acid Composition, Oxidative and Inflammatory Status, and Adherence to the Mediterranean Diet of Patients with Non-Alcoholic Fatty Liver Disease.
Monserrat-Mesquida M, Quetglas-Llabres M, Bouzas C, Pastor O, Ugarriza L, Llompart I
Antioxidants (Basel). 2023; 12(8).
PMID: 37627549
PMC: 10451635.
DOI: 10.3390/antiox12081554.
Multimodal assessment of non-alcoholic fatty liver disease with transmission-reflection optoacoustic ultrasound.
Lafci B, Hadjihambi A, Determann M, Konstantinou C, Freijo C, Herraiz J
Theranostics. 2023; 13(12):4217-4228.
PMID: 37554280
PMC: 10405839.
DOI: 10.7150/thno.78548.
Gut Microbiome in the Progression of NAFLD, NASH and Cirrhosis, and Its Connection with Biotics: A Bibliometric Study Using Dimensions Scientific Research Database.
Pezzino S, Sofia M, Mazzone C, Castorina S, Puleo S, Barchitta M
Biology (Basel). 2023; 12(5).
PMID: 37237476
PMC: 10215374.
DOI: 10.3390/biology12050662.
The growing burden of non-alcoholic fatty liver disease on mortality.
Cho J, Sohn W
Clin Mol Hepatol. 2023; 29(2):374-376.
PMID: 36880212
PMC: 10121311.
DOI: 10.3350/cmh.2023.0084.
The independent effect of exercise on biopsy proven non-alcoholic fatty liver disease: A systematic review.
Jin Y
Clin Mol Hepatol. 2023; 29(2):414-416.
PMID: 36858458
PMC: 10121307.
DOI: 10.3350/cmh.2023.0055.
Positive association between nonalcoholic fatty liver disease and growth hormone deficiency in patients with nonfunctioning pituitary adenoma.
Hwang Y, Lee H, Ahn S, Lee E, Ku C, Kim S
Front Endocrinol (Lausanne). 2023; 13:1057769.
PMID: 36699040
PMC: 9868829.
DOI: 10.3389/fendo.2022.1057769.
Multi-omics analysis of the effects of dietary changes and probiotics on diet-induced obesity.
Jiang S, Su Y, Wang Q, Lv L, Xue C, Xu L
Curr Res Food Sci. 2023; 6:100435.
PMID: 36691590
PMC: 9860293.
DOI: 10.1016/j.crfs.2023.100435.
Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinoma.
Cernea S, Onisor D
World J Gastroenterol. 2023; 29(2):286-309.
PMID: 36687124
PMC: 9846941.
DOI: 10.3748/wjg.v29.i2.286.